Fused bicyclic or tricyclic amino acids
US6596900B2 · kind B2 · utility
42Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2002 |
| Grant date | Jul 22, 2003 |
| Priority date | — |
| Expiry date | Apr 16, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the instant invention are bicyclic or tricyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, sleep disorders, visceral pain disorders, and gastrointestinal disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.